← Open Payments lookup

VERONICA KANG: Open Payments

NPI 1801815998 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,133 in 51 payments from 6 companies in 2025. Trend: 2023 $66 · 2024 $588 · 2025 $1,133

Food & beverage: $1,133
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.38$798
E.R. Squibb & Sons, L.L.C.5$138
Luye Pharma (USA) Ltd.3$81
Alkermes, Inc.3$62
Janssen Pharmaceuticals, Inc1$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: UZEDY, COBENFY, ERZOFRI EXTENDED-RELEASE, ARISTADA, SPRAVATO, CAPLYTA.

Industry payments across CA — which companies pay providers there.